Treatment of eosinophilic esophagitis: How should we manage the disease?

Journal of Clinical Gastroenterology

Volumn 44, Issue 10, 2010, Pages 663-671

  González Castillo, Sonia ^a   Arias, Ángel ^a   Lucendo, Alfredo J ^a  

^a HOSPITAL GENERAL DE TOMELLOSO   (Spain)

Author keywords

endoscopic dilation; eosinophilic esophagitis; nutritional management; topical steroids; treatment

Indexed keywords

ALLERGEN; ANTIINFLAMMATORY AGENT; AZATHIOPRINE; ESOMEPRAZOLE; FLUTICASONE; FLUTICASONE PROPIONATE; MEPOLIZUMAB; MERCAPTOPURINE; METHYLPREDNISOLONE; MONTELUKAST; PLACEBO; PREDNISONE; PROTON PUMP INHIBITOR;

ASTHMA; CD8+ T LYMPHOCYTE; CLINICAL FEATURE; CLINICAL TRIAL; DIETARY INTAKE; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; ELEMENTAL DIET; EOSINOPHILIC ESOPHAGITIS; ESOPHAGOSCOPY; FOOD ALLERGY; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HISTOPATHOLOGY; HUMAN; INFLAMMATION; MAST CELL; PATCH TEST; PRIORITY JOURNAL; REVIEW; SKIN TEST;

ANTI-INFLAMMATORY AGENTS; DIET; EOSINOPHILIC ESOPHAGITIS; ESOPHAGOSCOPY; GASTROINTESTINAL AGENTS; HUMANS; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; RISK REDUCTION BEHAVIOR; TREATMENT OUTCOME;

EID: 77958458737     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3181f189af     Document Type: Review

References (86)

1. Attwood SE, Smyrk TC, Demeester TR, et al. Esophageal eosinophilia with dysphagia: a distinct clinicopathologic syndrome. Dig Dis Sci. 1993;38:109-116.
2. Furuta GT, Straumann A. Review article: the pathogenesis and management of eosinophilic esophagitis. Aliment Pharmacol Ther. 2006;24:173-182.
3. Lucendo AJ. Immunopathological mechanisms of eosinophilic esophagitis. Allergol Inmunopathol (Madr). 2008;36:215-227.
4. Spechler SJ, Genta RM, Souza RF. Thoughts on the complex relationship between gastroesophageal reflux disease and eosinophilic esophagitis. Am J Gastroenterol. 2007;102: 1301-1306.
5. Konikoff MR, Noel RJ, Blanchard C, et al. A randomized double-blind, placebo controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology. 2006; 131:1381-1391.
6. Schaefer ET, Fitzgerald JF, Molleston JP, et al. Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children. Clin Gastroenterol Hepatol. 2008;6:165-173.
7. Peterson KA, Thomas KL, Hilden K, et al. Comparasion of esomeprazole to aerosolized, swallowed fluticasone for eosino-philic esophagitis. Dig Dis Sci. 2010;55:1313-1319.
8. Kelly KJ, Lazenby AJ, Rowe PC, et al. Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology. 1995; 109:1503-1512.
9. Spergel JM, Beausoleil JL, Mascarenhas M, et al. The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis. J Allergy Clin Inmunol. 2002;109: 363-368.
10. Spergel JM, Andrews T, Brown-Whitehorn TF, et al. Treatment of eosinophilic esophagitis with specific elimination diet directed by a combination of skin prick and patch test. Ann Allergy Asthma Immunol. 2005;95:336-343.
11. Lucendo AJ, Bellon T, Lucendo B. The role of mast cell in eosinophilic esophagitis. Pediatr Allergy Immunol. 2009;20: 512-518.
12. Markowitz JE, Spergel JM, Ruchelli E, et al. Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents. Am J Gastroenterol. 2003;98:777-782.
13. Liacouras CA, Spergel JM, Ruchelli E, et al. Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol. 2005;3:1198-1206.
14. Kagalwalla AF, Sentongo TA, Ritz S, et al. Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis. Ciln Gastroenterol Hepatol. 2006;119: 1097-1102.
15. Gonsalves N, Ritz S, Yang G, et al. A prospective clinical trial of allergy testing and food elimination diet in adults with eosinophilic esophagitis (EE). Gastroenterology. 2007;132 (suppl 1):A6-A7.
16. Spergel JM, Shuker M. Nutritional management of eosino-philic esophagitis. Gastrointest Endosc Clin N Am. 2008;18: 179-194.
17. Furuta GT, Liacouras CA, Collins MH, et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology. 2007;133:1342-1363.
18. Molina-Infante J, Ferrando-Lamana L, Mateos-Rodriguez JM, et al. Overlap of reflux and eosinophilic esophagitis in two patients requiring different therapies: a review of the literature. World J Gastroenterol. 2008;14:1463-1466.
19. Putnam PE, Rothenberg ME. Eosinophilic esophagitis: concepts, controversies, and evidence. Curr Gastroenterol Rep. 2009;11:220-225.
20. Nurko S, Teitelbaum JE, Husain K, et al. Association of Schatzki ring with eosinophilic esophagitis in children. J Pediatr Gastroenterol Nutr. 2004;38:436-441.
21. Ngo P, Furuta G, Antonioli D, et al. Eosinophils in the esophagus\Peptic or allergic eosinophilic esophagitis? Case series of three patients with esophageal eosinophilia. Am J Gastroenterol. 2006;101:1666-1670.
22. Liacouras CA, Wenner WJ, Brown K, et al. Primary eosinophilic esophagitis in children: successful treatment with oral corticosteroids. J Pediatr Gastroenterol Nutr. 1998;26: 380-385.
23. King J, Khan S. Eosinophilic esophagitis: perspectives of adult and pediatric gastroenterologists. Dig Dis Sci. 2010;55: 973-982.
24. Faubion WA, Perrault J, Burgart LJ, et al. Treatment of eosinophilic esophagitis with inhaled corticosteroids. J Pediatr Gastroenterol Nutr. 1998;27:90-93.
25. Noel RJ, Putman PE, Collins MH, et al. Clinical and inmunopathologic effects of swallowed fluticasone for eosino-philic esophagitis. Clin Gastroenterol Hepatol. 2004;2:568-575.
26. Arora AS, Perrault J, Smyrk TC. Topical corticosteroid treatment of dysphagia due to eosinophilic esophagitis. Mayo Clin Proc. 2003;78:830-835.
27. Teitelbaum J, Fox V, Twarog F, et al. Eosinophilic Esophagitis in Children: inmunopathological analysis and response to fluticasone propionate. Gastroenterology. 2002;122:1216-1225.
28. Langdon DE. Fluticasone in eosinophilic corrugated ringed esophagus. Am J Gastroenterol. 2001;96:926-927.
29. Lucendo Villarin A, Carrion Alonso G, Navarro Sanchez M, et al. Eosinophilic esophagitis in adults, an emerging cause of dysphagia: description of 9 cases. Rev Esp Enf Dig. 2005; 97:229-234.
30. Martin-Munoz MF, Lucendo AJ, Navarro M, et al. Food allergy and eosinophilic esophagitis: two cases studies. Digestion. 2006;74:49-54.
31. Lucendo AJ, Pascual-Turrion JM, Navarro M, et al. Endo-scopic, bioptic and manometric findings in eosinophilic esophagitis before and after steroid therapy: a case series. Endoscopy. 2007;39:765-771.
32. Lucendo AJ, Navarro M, Comas C, et al. Immunophenotypic characterisation and quantification of the epithelial inflammatory infiltrate in eosinophilic esophagitis through stereology: an analysis of the disease's cellular mechanisms and the esophagus's immunological capacity. Am J Surg Pathol. 2007; 31:598-606.
33. Lucendo AJ, Castillo P, Martin-Chavarri S, et al. Manometric findings in adult eosinophilic oesophagitis: a study of 12 cases. Eur J Gastroenterol Hepatol. 2007;19:417-424.
34. Remedios M, Campbell C, Jones DM, et al. Eosinophilic esophagitis in adults: clinical, endoscopic, histologic findings, and response to treatment with fluticasone propionate. Gastrointest Endosc. 2006;63:3-12.
35. Perrault J, Arora AS, Clawson ML, et al. Treatment of eosinophilic esophagitis with steoid lavage in adult patients (abstract). Am J Gastroenterol. 2001;96:S31.
36. Aceves SS, Dohil R, Newbury RO, et al. Topical viscous budesonide suspension for treatment of eosinophilic esophagi-tis. J Allergy Clin Immunol. 2005;116:705-706.
37. Moots RJ, Prouse P, Gumpel JM. Near fatal eosinophilic gastroenteritis responded to oral sodium cromoglycate. Gut. 1998;29:1282-1285.
38. Attwood SE, Lewis CJ, Bronder CS, et al. Eosinophilic esophagitis: a novel treatment using Montelukast. Gut. 2003; 52:181-185.
39. Gupta SK, Peters-Golden M, Fitzgerald JF, et al. Cysteinil leukotriene levels in esophageal mucosal biopsies of children with eosinophilic inflamation: are they all the same? Am J Gastroenterol. 2006;101:1125-1128.
40. Netzer P, Gschossmann JM, Straumann A, et al. Cortico-steroid-dependent eosinophilic oesophagitis: azathioprine and 6-mercaptopurine can induce and maintain long-term remission. Eur J Gastroenterol Hepatol. 2007;19:865-689.
41. Yamazaki K, Murray JA, Arora AS, et al. Allergen-specific in vitro cytokine production in adult patients with eosinophilic esophagitis. Dig Dis Sci. 2006;51:1934-1941.
42. Straumann A, Bauer M, Fischer B, et al. Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response. J Allergy Clin Immunol. 2001;108: 954-961.
43. Lucendo AJ, De Rezende L, Comas C, et al. Treatment with topic steroids downregulates IL-5, eotaxin-1/CCL11 and eotaxin-3/CCL26 gene expression in eosinophilic esophagitis. Am J Gastroenterol. 2008;103:2184-2193.
44. Mishra A, Hogan SP, Brandt EB, et al. IL-5 promotes eosinophil trafficking to the esophagus. J Inmunol. 2001;168: 2464-2469.
45. Kim YJ, Prussin C, Martin B, et al. Rebound eosinophilia after treatment of hypereosinophilic syndrome and eosinophi-lic gastroenteritis with monoclonal anti-IL-5 antibody SCH55700. J Allergy Clin Inmunol. 2001;114:1449-1455.
46. Garrett JK, Jameson SC, Thomson B, et al. Anti-interleukin-5 (mepolizumab) therapy for hipereosinophilic syndromes. J Allergy Clin Inmunol. 2003;113:115-119.
47. Stein ML, Collins MH, Villanueva JM, et al. Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. J Allergy Clin Immunol. 2006;118:1312-1319.
48. Straumann A, Conus S, Grzonka P, et al. Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomized, placebo-controlled, double-blind trial. Gut. 2010;59:21-30.
49. Foroughi S, Foster B, Kim N, et al. Anti-IgE treatment of eosinophilic-associated gastrointestinal disorders. J Allergy Clin Immunol. 2007;120:594-601.
50. Echeverria Zudaire L, Fernandez Fernandez S, Rayo Fernandez A, et al. No eficacia de omalizumab (Xolair) en el tratamiento de un paciente con esofagitis eosinofilica. Allergol Inmunopathol (Madr). 2008;36(extraordinario 1):68-69.
51. Straumann A, Bussmann C, Conus S, et al. Anti-TNF-alpha (infliximab) therapy for severe adult eosinophilic esophagitis. Gastroenterology. 2008;122:425-427.
52. Blanchard C, Mingler MK, Vicario M, et al. IL-13 involvement in eosinophilic esophagitis: trasncriptome analysis and reversibility with glucocorticoids. J Allergy Clin Immunol. 2007;120:1292-1300.
53. Blanchard C, Wang N, Stringer KF, et al. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest. 2006;116:536-547.
54. Mulder DJ, Pacheco I, Hurlbut DJ, et al. FGF9-iduced proliferative response to eosinophilic inflammation in oeso-phagitis. Gut. 2009;58:166-173.
55. Sano Y, Yamada H. Progress in suplatast tosilate research. Clin Exp Allergy. 2007;37:970-972.
56. Myou S, Fujimura M, Kurashima H, et al. Effects of suplatast tosilate, a new type of anti-allergic agent, on airway cough hypersensitivity induced by airway allergy in ginea-pigs. Clin Exp Allergy. 2001;31:1939-1944.
57. Shirai T, Hashimoto D, Suzuki K, et al. Successful treatment of eosinophilic gastroenteritis with suplatast tosilate. J Allergy Clin Inmunol. 2001;107:924-925.
58. Prasad GA, Arora AS. Spontaneous perforation in the ringed esophagus. Dis Esophagus. 2005;18:406-409.
59. Cohen MS, Kaufman A, Dimarino AJ Jr, et al. Eosinophilic esophagitis presenting as spontaneous esophageal rupture (Boerhaave's syndrome). Clin Gastroenterol Hepatol. 2007;5:A24.
60. Kaplan M, Mutlu EA, Jakate S, et al. Endoscopy in eosinophilic esophagitis: 'feline' esophagus and perforation risk. Clin Gastroenterol Hepatol. 2003;1:433-437.
61. Straumann A, Bussmann C, Zuber M, et al. Eosinophilic esophagitis: analysis of food impaction and perforation in 251 adolescent and adult patients. Clin Gastroenterol Hepatol. 2008;6:598-600.
62. Aceves SS, Newbury RO, Dohil R, et al. Esophageal remodeling in pediatric eosinophilic esophagitis. J Allergy Clin Immunol. 2007;119:206-212.
63. Mishra A, Wang M, Pemmaraju VR, et al. Esophageal remodeling develops as a consequence of tissue especific IL-5-induced eosinophilia. Gastroenterology. 2008;134:204-214.
64. Nurko S, Teitelbaum J, Husain K, et al. Association os Schatzki ring with eosinophilic esophagitis in children. J Pediatr Gastroenterol Nutr. 2004;38:431-441.
65. Riou PJ, Nicholson AG, Pastorino U. Esophageal rupture in a patient with idiopathic eosinophilic esophagitis. Ann Thorac Surg. 1996;62:1856.
66. Morrow JB, Vargo JJ, Goldblum JR, et al. The ringed esophagus: histological features of GERD. Am J Gastroenterol. 2001;96:984-989.
67. Vasilopoulos S, Murphy P, Auerbach A, et al. The small-caliber esophagus: an unappreciated cause of dysphagia for solids in patients with eosinophilic esophagitis. Gastrointest Endosc. 2002;55:99-106.
68. Straumann A. The natural history and complications of eosinophilic esophagitis. Gastrointestinal Endosc Clin North Am. 2008;18:99-118.
69. Croese J, Fairley SK, Masson JW, et al. Clinical and endoscopic features of eosinophilic esophagitis in adults. Gastrointest Endosc. 2003;58:516-522.
70. Straumann A, Spichtin HP, Grize L, et al. Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years. Gastroenterology. 2003;125: 1660-1669.
71. Potter JW, Saeian K, Staff D, et al. Eosinophilic esophagitis in adults: an emerging problem with unique esophageal features. Gastrointest Endosc. 2004;59:355-361.
72. Langdon DE. Response to Straumann et al: primary eosino-philic esophagitis. Gastroenterology. 2005;127:364.
73. Zimmermann SL, Levine MS, Rubesin SE, et al. Idiopathic eosinophilc esophagitis in adults: the ringed esophagus. Radiology. 2005;236:159-165.
74. Cantu P, Velio P, Prada A, et al. Ringed oesophagus and idiopathic eosinophilic oesophagitis in adults: an association in two cases. Dig Liv Dis. 2005;37:129-134.
75. Eisenbach C, Merle U, Schirmacher P, et al. Perforation of the esophagus after dilation treatment for dysphagia in a patient with eosinophilic esophagitis. Endoscopy. 2006;38: E43-E44.
76. Zuber-Jerger I, Ratiu N, Kullman F. Long-lasting effect of endoscopic dilation of an esophageal stenosis due to eosinophilic esophagitis. J Gastrointestin Liver Dis. 2006;15: 167-170.
77. Pasha SF, DiBaise JK, Kim HJ, et al. Patient characteristics, clinical, endoscopic, and histologic findings in adult eosinophilic esophagitis: a case series and systematic review of the medical literature. Dis Esophagus. 2007;20: 311-319.
78. Schoepfer AM, Gonsalves N, Bussmann C, et al. Esophageal dilation in eosinophilic esophagitis: effectiveness, safety, and impact on the underlying inflammation. Am J Gastroenterol. 2010;105:1062-1070.
79. Rajagopalan J, Triadafilopoulos G. Ring(s)-related esophageal meat bolus impaction: biopsy first, dilate later. Dis Esophagus. 2009;22:E-16.
80. Roberts-Thomson IC. Gastrointestinal: eosinophilic esophagi-tis. J Gastroenterol Hepatol. 2005;29:1299.
81. Cohen MS, Kaufman AB, Palazzo JP, et al. An audit of endoscopic complications in adult eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2007;5:1149-1153.
82. Liguori G, Cortale M, Cimino F, et al. Circumferential mucosal dissection and esophageal perforation in a patient with eosinophilic esophagitis. World J Gastroenterol. 2008;14: 803-804.
83. Schoepfer AM, Gschossmann J, Scheurer U, et al. Esophageal strictures in adult eosinophilic esophagitis: dilation is an effective and safe alternative after failure of topical cortico-steroids. Endoscopy. 2008;40:161-164.
84. Lucendo AJ, De Rezende L. Endoscopic dilation for treatment of eosinophilic esophagitis: a strategy with a high perforation risk. Endoscopy. 2007;39:376.
85. Straumann A, Rossi L, Simon HU, et al. Fragility of the esophageal mucosa: a pathognpmonic endoscopic sign of primary eosinophilic esophagitis? Gastrointest Endosc. 2003;57: 407-412.
86. Molina-Infante J, Ferrando-Lamana L, Fernandez-Bermejo M, et al. Eosinophilic esophagitis in GERD patients: a clinicopathological diagnosis using proton pump inhibitors. Am J Gastroenterol. 2009;104:2856-2857.